← Open Payments lookup

MURALI VEERAMACHANENI: Open Payments

NPI 1851374367 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,166 in 55 payments from 13 companies in 2025. Trend: 2023 $895 · 2024 $865 · 2025 $1,166

Food & beverage: $1,166
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$177
Collegium Pharmaceutical, Inc.9$153
Supernus Pharmaceuticals, Inc.5$108
Alkermes, Inc.5$107
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$107
Otsuka America Pharmaceutical, Inc.4$102
E.R. Squibb & Sons, L.L.C.4$100
Teva Pharmaceuticals USA, Inc.4$82
Lundbeck LLC3$76
ABBVIE INC.3$64

Products named: INGREZZA, Jornay PM, REXULTI, Qelbree, ARISTADA, CAPLYTA, COBENFY, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.